I do agree, if such conditions actually exist. I’m not certain that they do, at least not to a degree that would impact performance significantly on their own. I’d be much more concerned with hormonal, autocrine/paracrine, and histo-immune factors, since these are going to determine how much training the individual can perform and recover from in a reasonable time frame. When considering performance, anatomical structure aside, the nervous system is only one part of the game.
However, even in that case, I want to add the caveat that it isn’t the particular MHC isoform being expressed that is “at fault” for the change in performance. It’s the neural “wiring” for the FT/ST ratio. MHC expression doesn’t affect performance-- the shift from so-called “fast” to “slow” isoforms is the observed shift from IIx -> IIa. MHC IIx doesn’t do anything in humans, apparently. It’s a marker of disuse and of detraining. That suggests that it isn’t very appropriate for strength or speed, on its own merit, let alone the continuing research showing that it is indeed neural output that is responsible for functional characteristics. The fiber types only follow the function of the fiber.
When you bear in mind that the only real difference between IIx and IIa is the shortening velocity, not force production, it makes sense. IIx is thought to contract “too fast” to be of any use in strength training activity, and this fits observation. Additionally, I’m not aware of any reasons why any program using weights ~60% or higher, following all the usual protocols (fast, heavy, whatever) would result in a shift to MHC-I. That just doesn’t happen; type I expresses under heavy aerobic conditions, as a way of making the fiber more efficient, not during any strength activities.